2018
DOI: 10.3389/fnmol.2018.00004
|View full text |Cite
|
Sign up to set email alerts
|

Function of B-Cell CLL/Lymphoma 11B in Glial Progenitor Proliferation and Oligodendrocyte Maturation

Abstract: B-cell CLL/lymphoma 11B (Bcl11b) – a C2H2 zinc finger transcriptional factor – is known to regulate neuronal differentiation and function in the development of the central nervous system (CNS). Although its expression is reduced during oligodendrocyte (OLG) differentiation, its biological role in OLGs remains unknown. In this study, we found that the downregulation of Bcl11b gene expression in glial progenitor cells (GPCs) by lentivirus-mediated gene knockdown (KD) causes a reduction in cell proliferation with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 44 publications
0
9
0
Order By: Relevance
“…Specifically, we found BCL11B (CTIP2), a negative regulator of glial progenitor cell differentiation to be significantly increased at the glial scar (Fig. 8d , left) 53 . Conversely, we found RXRG, a positive regulator of OPC differentiation, and remyelination, to be significantly depleted (Fig.…”
Section: Resultsmentioning
confidence: 83%
“…Specifically, we found BCL11B (CTIP2), a negative regulator of glial progenitor cell differentiation to be significantly increased at the glial scar (Fig. 8d , left) 53 . Conversely, we found RXRG, a positive regulator of OPC differentiation, and remyelination, to be significantly depleted (Fig.…”
Section: Resultsmentioning
confidence: 83%
“…OPCs that were generated from neural stem cells derived from the brain tissues of mouse embryos at 14.5 days were plated onto poly- d -lysine (PDL; Sigma; Cat# P0899) -coated dishes and maintained in the growth medium consisting of DMEM/F12 medium (Thermo Fisher, Cat# 12400024), 2% B27 supplement (Thermo Fisher; Cat# 17504044), 1% N2 supplement (Thermo Fisher; Cat# 17502048), 10 ng/ml epidermal growth factor (ProSpec; Cat# GFH-26-100), 10 ng/ml fibroblast growth factor-2 (Cell Guidance Systems; Cat# PPH146), and 10 ng/ml platelet-derived growth factor-AA (ProSpec; Cat# CYT-341). To induce the differentiation of OPCs into mature OLGs with expression of myelin proteins [31], OPCs were cultured for 7 days in OLG differentiation medium (DM) containing DMEM medium (Thermo Fisher; Cat# 12100-046), 1% Penicillin–Streptomycin (Thermo Fisher; Cat#15140-122), 1 mM sodium pyruvate (Sigma; Cat# P2256), 0.1% bovine serum albumin (Sigma; Cat# A7030), 50 μg/ml apotransferrin (Sigma; Cat# T2252), 5 μg/ml insulin (Sigma; Cat# I6634), 30 nM sodium selenite (Sigma; Cat# S5261), 10 nM biotin (Sigma; Cat# B4639), 10 nM hydrocortisone (Sigma; Cat# H0888), 15 nM triiodothyronine (Sigma; Cat# T6397), 10 ng/ml ciliary neurotrophic factor (ProSpec; Cat# CYT-272), and 5 μg/ml N-acetyl-cysteine (Sigma; Cat# A9165). To determine the effect of IL-33 on OLG maturation, OLGs after a 6-day incubation in DM were continuously treated with mouse recombinant IL-33 (CellGS, Cat# GFM36) in DM for 24 h.…”
Section: Methodsmentioning
confidence: 99%
“…In oligodendrocytes, 56 TF motifs were significantly different between the stroke and contralateral hemisphere, many of which (78.6%) corresponded to higher enrichment in stroke as compared to contralateral. Specifically, we found BCL11B (CTIP2), a negative regulator of glial progenitor cell differentiation to be significantly increased at the glial scar around the infarct (Figure 4i, left) 51 .…”
Section: Scimap-atac In Cerebral Ischemia Reveals Spatially Progressimentioning
confidence: 91%